Summary
80 / 100 · Bulios Score
What speaks for it
- Out of every 100 THB of revenue, 30 THB is left as net profit.
- It earns 26 THB a year on every 100 THB of invested capital.
- It holds more cash than debt: ฿3.90B against ฿418.9M.
- Earnings per share grew by 14% a year over the last 3 years.
What to watch
- It pays out more in dividends than it earns: 139% of profit.
- Revenue growth is slowing: 6.6% a year over the last 3 years against 15% over 5 years.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedPrice against the Bulios Fair Price
P/E against the industry (Medical - Care Facilities)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 16.7 THB for 1 THB of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (THB)
Diluted EPS (THB)
- Analyst estimate
Revenue grew by 15% a year over 5 years. Over the last 3 years it grew by 6.6% a year. For the next fiscal year analysts expect revenue to grow by 2.8%. Earnings per share grew by 14% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 THB of revenue goes
- Cost of sales 48 THB
- Sales and administration 16 THB
- Taxes and other 6.0 THB
- Net profit 30 THB
Net profit, industry median (Medical - Care Facilities) 39 THB
Out of every 100 THB of revenue, 30 THB is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 8.36%
- Paid out of profit
- 139%
- Raised in a row
- 3 years
You receive $0.12 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.